Skip to main content

Table 3 Post-booster anti-HBs titre by vaccine group.

From: A cohort study to evaluate persistence of hepatitis B immunogenicity after administration of hexavalent vaccines

Anti-HBs titer (mIU/ml)

Group 1 (N = 25) Hexavac® n (%)

Group 2 (N = 5) Infanrix Hexa® n (%)

p-value

< 10

2 (8.0)

0

1.0000*

10–99

4 (16.0)

2 (40.0)

0.2854**

≥ 100

19 (76.0)

3 (60.0)

-

  1. * < 10 vs ≥ 10; ** 10–99 vs ≥ 100